AC
Aisling Capital Portfolio holdings
AUM
$45.3M
This Quarter Return
+22.22%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
–
AUM
$561M
AUM Growth
+$561M
(+11%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
$12.9M |
| 2 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$4.95M |
Sector Composition
| 1 | Healthcare | 77.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $397M | 70.71% | 3,438,920 | – | – |
|
|
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $71.3M | 12.71% | 2,240,000 | – | – |
|
|
VRAY
3
DELISTED
ViewRay, Inc.
VRAY
| $48.1M | 8.57% | 7,480,887 | – | – |
|
|
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
| $16.8M | 3% | 9,889,352 | – | – |
|
5
ADMA Biologics
ADMA
$4.12B
| $16.6M | 2.96% | 3,608,171 | – | – |
|
6
Cidara Therapeutics
CDTX
$1.66B
| $4.09M | 0.73% | 1,021,148 | – | – |
|
|
AGRX
7
DELISTED
Agile Therapeutics, Inc
AGRX
| $3.35M | 0.6% | 1,304,933 | – | – |
|
|
CMRX
8
DELISTED
Chimerix, Inc.
CMRX
| $2.46M | 0.44% | 472,943 | – | – |
|
|
PTX
9
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $502K | 0.09% | 210,000 | – | – |
|
|
SYRS
10
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – | -508,565 | Closed | -$4.95M |
|
|
ENTL
11
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| – | – | -528,655 | Closed | -$12.9M |
|